BP1123

Rizatriptan benzoate

British Pharmacopoeia (BP) Reference Standard

• Synonyme(s) : Rizatriptan benzoate salt, MK-462, N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt
• Formule empirique (notation de Hill): C₁₅H₁₉N₅ · C₇H₆O₂
• Numéro CAS: 145202-66-0
• Poids moléculaire : 391.47
• Numéro MDL: MFCD00866224
• Code UNSPSC : 41116107
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: pharmaceutical primary standard
• Famille d'API: rizatriptan
• Forme: crystalline
• Durée de conservation: limited shelf life, expiry date on the label
• Fabricant/nom de marque: BP
• Application(s): pharmaceutical; pharmaceutical small molecule
• Format: neat
• Température de stockage: 2-8°C
• Chaîne SMILES: OC(=O)c1ccccc1.CN(C)CCc2c[nH]c3ccc(Cn4cncn4)cc23
• InChI: 1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
• Clé InChI: JPRXYLQNJJVCMZ-UHFFFAOYSA-N
• Informations sur le gène: human ... HTR1B(3351) , HTR1D(3352)

Description

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Rizatriptan benzoate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Rizatriptan Tablets

Rizatriptan Orodispersible Tablets

Actions biochimiques/physiologiques

Rizatriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine.

Conditionnement

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Autres remarques

Sales restrictions may apply.